Publications by authors named "G R Bushee"

Article Synopsis
  • Pediatric urinary tract infections (UTIs) require timely diagnosis and proper treatment to minimize health issues, with a study showing inconsistent management practices among 13,000 children regarding antibiotic choices.
  • A local team recommended cephalexin as the preferred first-line treatment in 2019 due to its effectiveness, low cost, and ease of use, aiming to boost its prescription rates from 34% to 75% within six months.
  • After implementing standardized care pathways and provider education, the prescribing rate for cephalexin increased to 66%, demonstrating improved adherence to guidelines without affecting the rate of return visits for UTIs.
View Article and Find Full Text PDF
Article Synopsis
  • This study analyzed 2,685 children aged 2 months to 18 years who were treated with oral antibiotics for confirmed urinary tract infections (UTIs).
  • The main outcomes measured were hospital re-visits within 30 days and changes to antibiotic treatment within 14 days, with cefdinir showing lower modification rates compared to cephalexin and sulfamethoxazole-trimethoprim.
  • Cephalexin was suggested as a preferred first-line treatment due to its lower side effects and effective performance in treating uncomplicated pediatric UTIs.
View Article and Find Full Text PDF

Background: Our internal infant sepsis evaluation clinical practice guideline recommends infants with negative culture results who are undergoing sepsis evaluation receive antibiotics until culture results are negative for a maximum of 36 hours. The aims of our project were to decrease the percentage of patients who received >30 hours of administered antibiotic doses (recognizing effective concentrations last until hour 36) and increase 36-hour phrase documentation by using clinical decision support tools.

Methods: We used quality improvement methodology to study infants aged ≤60 days with negative culture results.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to compare the clinical outcomes of extended versus standard infusions of beta-lactam antibiotics in hospitalized pediatric patients, focusing on drugs like cefepime, piperacillin-tazobactam, and meropenem.
  • - A total of 551 patients were reviewed, and overall, the clinical outcomes were similar for both infusion methods; however, some subgroups showed significant differences.
  • - Critical care patients receiving extended infusions had lower mortality rates, and bone marrow transplant patients experienced fewer readmissions, suggesting potential benefits in these specific populations.
View Article and Find Full Text PDF